In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and What are peptides? FDA may ease restrictions on unproven health fad LiveNOW from FOX Compounded "semaglutide" is not FDA approved semaglutide.com RFK Jr. and the Perils of Peptides Washington Monthly Why Are People Injecting Themselves with Peptides? The New Yorker